Platform Technology Partners
Source: SEC Form 13F · as of Mar 2026Platform Technology Partners holds 21 biotech & pharma companies tracked by BioSniper, totaling $25.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$25.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 25,544 | $6.2M |
| AMGNAMGEN INC | 8,387 | $3.0M |
| LLYELI LILLY & Co | 2,590 | $2.4M |
| ABBVAbbVie Inc. | 10,844 | $2.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 6,893 | $1.9M |
| MRKMerck & Co., Inc. | 14,432 | $1.7M |
| PMPhilip Morris International Inc | 8,752 | $1.4M |
| BMYBRISTOL MYERS SQUIBB CO | 21,517 | $1.3M |
| ZTSZoetis Inc. | 7,127 | $842K |
| ABTABBOTT LABORATORIES | 6,737 | $692K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,448 | $647K |
| PFEPFIZER INC | 22,996 | $646K |
| GILDGILEAD SCIENCES, INC. | 3,279 | $457K |
| NVSNovartis AG | 2,984 | $456K |
| NVONovo Nordisk A/S | 7,862 | $289K |
| CAHCardinal Health Inc. | 1,329 | $281K |
| IQVIQVIA Holdings Inc. | 1,400 | $239K |
| BIIBBIOGEN INC. | 1,201 | $220K |
| ELVElevance Health Inc. | 715 | $209K |
| CGENCOMPUGEN LTD | 55,000 | $117K |
| GERNGERON CORP | 10,100 | $15K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.